# SignalRX Pharmaceuticals, Inc — Form D

SignalRX Pharmaceuticals, Inc of CUMMING, GA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-03. The offering totals $485K, of which $250K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2023-05-03
- Form: D
- Accession: 0001974464-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $485K
- Amount sold: $250K
- Remaining: $235K
- Minimum investment: $25K
- Investors: 2
- Date of first sale: 2022-09-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-480707

## Issuer

- Name: SignalRX Pharmaceuticals, Inc
- CIK: 0001974464
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2215 PILGRIM MILL CIRCLE, CUMMING, GA, 30041
- Phone: 7708159331

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Guillermo Morales | Director | Cumming, GA |
| Joel Wernick | Director | Cumming, GA |
| Matthew Williams | Director | Whitefish, MT |
| Matthew Williams | Executive Officer | Whitefish, MT |

## More

- [CIK 1974464 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1974464&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001974464-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.